Summary
- Current Price
- As of today, ZBIO price is $26.95, down -2.00% on
- Current Price All-Time High
- ZBIO price is currently -39.57% below its historical high of $44.60 set on
- Market Cap
- ZBIO current market cap is $2B, up +124.13% over the past 365 days
- Revenue
- ZBIO current annual revenue is $10.00M, up +100.00% year-over-year
- Next Earnings
- The next earnings release for ZBIO is on
Profile
| Metric | Value |
|---|---|
| Full Name | Zenas BioPharma, Inc. |
| Ticker | NASDAQ: ZBIO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | zenasbio.com |
| Employees | 130 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $26.95 | |
| Price, 1D Change | -2.00% | |
| $2B | ||
| - | ||
| - | ||
| 0.93 | ||
| $10.00M | ||
| Revenue, 1Y Change | +100.00% | |
| -$8.44 | ||
| EPS, 1Y Change | -124.82% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:2 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$8.44 | ||
| EPS Estimate | -$5.62 | N/A |
| EPS Est. Change | +33.51% | N/A |
| $10.00M | ||
| Revenue Estimate | $12.26M | N/A |
| Revenue Est. Change | +22.60% | N/A |
| Current Price | $26.95 | |
| Price Target | $45.00 | - |
| Price Tgt. Change | +66.98% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$7.04 | -$3.76 | +46.65% | |
| -$4.39 | -$8.44 | -92.36% | |
| -$5.62 | N/A | +33.51% | |
| -$4.66 | N/A | +44.82% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $5.00M | - | |
| $26.43M | $10.00M | -62.16% | |
| $12.26M | N/A | +22.60% | |
| $53.97M | N/A | +439.68% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $26.95 | |
| $25.54 | ||
| $31.58 | ||
| $25.94 | ||
| $30.35 | ||
| -$0.59 | ||
| 0.93 | ||
| $2.02 | ||
| 32.35 | ||
| 68.91% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $10.00M | ||
| -$8.44 | ||
| $9.94M | ||
| 99.44% | ||
| -$211.39M | ||
| -2,113.85% | ||
| -$377.74M | ||
| -3,777.37% | ||
| -$211.33M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.33 | ||
| 5.61 | ||
| 5.61 | ||
| - | ||
| - | ||
| 3.77 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 1,756.51 | ||
| 7.11 | ||
| -5.49 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $242.14M | ||
| $343.19M | ||
| $383.64M | ||
| $351.17M | ||
| $141.50M | ||
| $62.65M | ||
| $79.96M | ||
| $1.12M | ||
| $7.11M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $387.74M | ||
| $221.33M | ||
| $56.00K | ||
| $0.00 | ||
| $56.00K | ||
| $0.00 | ||
| -$79.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$172.33M | ||
| -$251.89M | ||
| $215.28M | ||
| $18.00K | ||
| -$172.35M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wedbush | → | |
| Morgan Stanley | → | |
| Guggenheim | → | |
| HC Wainwright & Co. | → | |
| Morgan Stanley | → | |
| Morgan Stanley | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| Citigroup | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with ZBIO
FAQ
- What is the ticker symbol for Zenas BioPharma, Inc.?
- The ticker symbol for Zenas BioPharma, Inc. is NASDAQ:ZBIO
- Does Zenas BioPharma, Inc. pay dividends?
- No, Zenas BioPharma, Inc. does not pay dividends
- What sector is Zenas BioPharma, Inc. in?
- Zenas BioPharma, Inc. is in the Healthcare sector
- What industry is Zenas BioPharma, Inc. in?
- Zenas BioPharma, Inc. is in the Biotechnology industry
- What country is Zenas BioPharma, Inc. based in?
- Zenas BioPharma, Inc. is headquartered in United States
- When did Zenas BioPharma, Inc. go public?
- Zenas BioPharma, Inc. initial public offering (IPO) was on September 13, 2024
- Is Zenas BioPharma, Inc. in the S&P 500?
- No, Zenas BioPharma, Inc. is not included in the S&P 500 index
- Is Zenas BioPharma, Inc. in the NASDAQ 100?
- No, Zenas BioPharma, Inc. is not included in the NASDAQ 100 index
- Is Zenas BioPharma, Inc. in the Dow Jones?
- No, Zenas BioPharma, Inc. is not included in the Dow Jones index
- When was Zenas BioPharma, Inc. last earnings report?
- Zenas BioPharma, Inc.'s most recent earnings report was on August 13, 2026
- When does Zenas BioPharma, Inc. report earnings?
- The next expected earnings date for Zenas BioPharma, Inc. is November 12, 2026
Data Sources & References
- ZBIO Official Website zenasbio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1953926/000110465926027964/0001104659-26-027964-index.htm
- ZBIO Profile on Yahoo Finance finance.yahoo.com/quote/ZBIO
- ZBIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/zbio